GENEVA, Switzerland—Alcon Inc. (SIX/NYSE: ALC), a global eyecare company, has announced the approval of all proposed resolutions at its 2022 annual general meeting (AGM), which was held late last month. The Alcon shareholders voted for all proposals at the AGM, including the election of Dr. Raquel C. Bono to the board. Dr. Bono is a board-certified trauma surgeon and retired vice admiral, U.S. Navy Medical Corps, as well as the first Asian-American woman promoted to vice admiral.

In addition, Alcon shareholders approved the operating and financial review of Alcon Inc., the annual financial statements of Alcon Inc. and the consolidated financial statements for 2021.
 
Shareholders approved a gross dividend of CHF 0.20 per dividend-bearing share be declared, and that, after appropriation of the proposed dividend, the remaining amount of available earnings be carried forward, according to the company’s recent announcement.
 
“We are delighted to welcome Dr. Bono to Alcon’s board,” said F. Michael Ball, the chair of the board of directors. “Dr. Bono brings a strong record of leadership in the health care industry, government relations and regulatory public policy that will add greatly to the expertise of our board.”
 
Shareholders also reelected Ball as chair of the board of directors, and all members of the board who stood for reelection, namely Lynn Bleil, Arthur Cummings, David Endicott, Thomas Glanzmann, D. Keith Grossman, Scott Maw, Karen May, Ines Pöschel and Dieter Spälti, for a term of one year.
 
In addition, shareholders reelected Glanzmann, May and Pöschel, and elected Maw, to form the compensation committee for a period of one year. The board designated May as the chair of the compensation committee with her reelection.
 
As a result of the situation due to the coronavirus COVID-19 pandemic, Alcon previously had directed shareholders to send their voting instructions to the independent representative, Hartmann Dreyer Attorneys-at-Law.